LISA WEINREICH: Open Payments
NPI 1285902767 · MISSOULA, MT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$828 in 33 payments from 9 companies in 2025. Trend: 2023 $387 · 2024 $653 · 2025 $828
Food & beverage: $828
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 2 | $159 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $152 |
| ABBVIE INC. | 7 | $150 |
| Madrigal Pharmaceuticals | 3 | $108 |
| Janssen Biotech, Inc. | 4 | $97 |
| Lilly USA, LLC | 3 | $58 |
| PFIZER INC. | 3 | $53 |
| Celltrion USA Inc. | 2 | $32 |
| Ardelyx, Inc. | 1 | $21 |
Products named: DUPIXENT, ENTYVIO, REZDIFFRA, TREMFYA, SKYRIZI, OMVOH, MAVYRET, VELSIPITY.
Industry payments across MT — which companies pay providers there.
